NCCTG N08CA (Alliance): The use of Glutathione for Prevention of Paclitaxel/Carboplatin Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo-Controlled Study
      QxMD      Google Scholar   
Citation:
Cancer vol 120 (12) 1890-1897
Year:
2014
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
3
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
CA37404, U10 CA035267, CA33601, CA35, 090, U10 CA052352, CA-63, 848, N01 CA035431, U10 CA035269, CA-35, 269, CA-25, 224, 272, K05 CA124477, 195, U10 CA031946, U10 CA033601, U10 CA037404, 448, U10 CA035448, U10 CA063848, 267, U10 CA035195, N01 CA063844, U10 CA035272, P30 CA015083, U10 CA063849, CA52352, U10 CA035431, CA63849, U10 CA025224, CA63844, U10 CA035090, CA31946, CA35103, U10CA063844, CA35431, U10CA035103  
Corr. Author:
 
Authors:
                       
Networks:
 
Study
NCCTG-N08CA
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
glutathione, chemotherapy induced peripheral neuropathy, prevention, paclitaxel, carboplatin